Penn Virginia PT Lowered to $6.50 (PVA)

Penn Virginia (NYSE: PVA) had its price target decreased by Canaccord Genuity from $8.00 to $6.50 in a research report sent to investors on Friday morning.

Shares of Penn Virginia traded up 1.19% during mid-day trading on Friday, hitting $4.24. Penn Virginia has a one year low of $3.92 and a one year high of $7.74. The stock’s 50-day moving average is currently $4.50. The company’s market cap is $227.3 million.

A number of other analysts have also recently weighed in on PVA. Analysts at Howard Weil upgraded shares of Penn Virginia from a sector perform rating to a sector outperform rating in a research note to investors on Wednesday, February 6th. Separately, analysts at Zacks upgraded shares of Penn Virginia from a neutral rating to an outperform rating in a research note to investors on Tuesday, February 5th. They now have a $5.20 price target on the stock. Finally, analysts at Barclays Capital reiterated an underweight rating on shares of Penn Virginia in a research note to investors on Wednesday, November 28th.

Eight investment analysts have rated the stock with a buy rating, three have issued an overweight rating, two have given a hold rating, and one has issued a sell rating to the company. The stock has a consensus rating of overweight and an average price target of $6.61.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.



Latest News

Unemployment Claims Drop as Consumer Comfort Increases
Unemployment Claims Drop as Consumer Comfort Increases
Senate Confirms first Indian American to Court of Appeals
Senate Confirms first Indian American to Court of Appeals
Apple Tax Scandal can Lead to the Scrapping of Corporate Tax
Apple Tax Scandal can Lead to the Scrapping of Corporate Tax
Military Charges Soldier for Filming Female Cadets
Military Charges Soldier for Filming Female Cadets
Herbalife Employs PwC as Auditor
Herbalife Employs PwC as Auditor
Drug Resistant TB Bacteria Killed by Vitamin C
Drug Resistant TB Bacteria Killed by Vitamin C


Leave a Reply

 
© 2010-2013 Zolmax.com, LLC.
Subscribe Subscribe